ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ligand, WuXi Biologics Amend Agreement
contractpharma
July 03, 2018Ligand Pharmaceuticals?has received $47 million as a result of signing an amendment relating to its OmniAb platform agreement with?WuXi Biologics. This amendment provides WuXi Bio more efficiency in expanding its OmniAb antibody discovery services. -
Ligand Earns Janssen Milestone
contractpharma
March 29, 2017CNA Development LLC has filed an IND for an antibody discovered using Ligand’s OmniAb technology triggering a $1 million milestone payment to Ligand.
Pharma Sources Insight January 2025
